Plain-English translation of NCT04425265 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer surgical technique called plasma radiofrequency ablation at low temperature works better than a standard surgical method (electrocautery block resection) for treating nasopharyngeal cancer that has returned. Nasopharyngeal cancer is cancer in the space behind your nose. You would be randomly assigned to receive one of these two surgical treatments to remove the recurrent cancer.
When nasopharyngeal cancer comes back after initial radiation therapy, surgery is often needed. Doctors want to find out if the newer plasma radiofrequency technique offers patients better survival rates and quality of life compared to the traditional surgical approach.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive one of the two surgical treatments to remove your recurrent cancer. The study will follow your health and survival over time to compare how well each approach works. You will need to attend follow-up visits so doctors can monitor your recovery and any side effects, though the exact visit schedule will be explained to you in detail before you enroll.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China